Skip to Content

Join the 'Diabetes, Type 2' group to help and get support from people like you.

Diabetes, Type 2 News (Page 3)

Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2

Underactive Thyroid May Raise Odds for Type 2 Diabetes: Study

Posted 4 Apr 2016 by Drugs.com

MONDAY, April 4, 2016 – People with an underactive thyroid, or hypothyroidism, may be at greater risk for type 2 diabetes – even if their thyroid hormone levels are kept within normal range, a new study finds. As the Dutch researchers explained, thyroid hormones are essential for the regulation of metabolism – the conversion of food into either energy or fat. However, an underactive thyroid gland slows metabolism, and that can lead to weight gain, the scientists said. Prior studies suggested that hypothyroidism is tied to reduced insulin sensitivity – a precursor for type 2 diabetes. In the new eight-year-long study, a team led by Dr. Layal Chaker of Erasmus Medical Center in Rotterdam tracked almost 8,500 people averaging 65 years of age. All of the participants had a blood test to measure their blood sugar levels as well as their thyroid function. They were re-evaluated every few ... Read more

Related support groups: Diabetes, Type 2, Hypothyroidism, Underactive Thyroid, Hypothyroidism - After Thyroid Removal, Insulin Resistance, Pre-Diabetes, Diabetes Mellitus, Abnormal Glucose Tolerance

'Paleo' Diet May Help Older Women's Hearts, Waistlines

Posted 4 Apr 2016 by Drugs.com

SUNDAY, April 3, 2016 – The so-called Paleo diet may help older women lose weight, improve their cholesterol profile and lower future risk of diabetes and heart disease, a new study has found. Women experienced these benefits by sticking to the guidelines of the Paleo diet, even though they were not required to restrict their calorie intake, the researchers said. The study results indicate that the Paleo diet could prove an effective means of battling the obesity epidemic, said lead study author Caroline Blomquist, a doctoral student at Umea University in Sweden. The findings are scheduled for presentation Sunday at the annual meeting of the Endocrine Society, in Boston. The data and conclusions should be viewed as preliminary until published in a peer-reviewed journal. "Obesity-related disorders have reached pandemic proportions with significant economic burden on a global scale," ... Read more

Related support groups: Diabetes, Type 2, Obesity, High Cholesterol, Weight Loss, Insulin Resistance, Pre-Diabetes, Diabetes Mellitus, Cardiovascular Risk Reduction

Diabetes Meds Vary in Safety and Effectiveness, Study Shows

Posted 31 Mar 2016 by Drugs.com

THURSDAY, March 31, 2016 – A study of nearly a half-million people with type 2 diabetes shows there are pros and cons to nearly every form of drug therapy for the disease. In the British study, researchers looked at patient outcomes from a large U.K. database of almost 470,000 adults with type 2 diabetes, tracked between 2007 and 2015. Julia Hippisley-Cox and Carol Coupland, of the University of Nottingham, sought to parse out differences among a variety of diabetes drugs. They accounted for complicating patient factors such as age, sex, smoking and poverty, as well as how long a person had been diagnosed with type 2 diabetes. The researchers also focused on five major outcomes linked to diabetes: blindness, amputation, severe kidney failure, and high or low blood sugar. Reporting March 30 in BMJ, they found that when a class of drugs called glitazones (Actos, Avandia) was prescribed ... Read more

Related support groups: Diabetes, Type 2, Metformin, Glucophage, Glipizide, Janumet, Insulin Resistance, Glyburide, Actos, Pre-Diabetes, Glimepiride, Amaryl, Diabetes Mellitus, Avandia, Glucophage XR, Prandin, GlipiZIDE XL, Glucotrol, ActoPlus Met, Glucotrol XL, Glumetza

More Evidence Diabetes Drug Actos Raises Bladder Cancer Risk a Bit

Posted 31 Mar 2016 by Drugs.com

WEDNESDAY, March 30, 2016 – More evidence linking the diabetes drug Actos to an increased risk of bladder cancer has surfaced in a new study that also finds the risk rises with increased use. Actos (pioglitazone) appears to increase risk of bladder cancer by 63 percent, Canadian researchers say. The findings, published March 30 in The BMJ, stem from an analysis of nearly 146,000 patients treated between 2000 and 2013. The data also showed that bladder cancer risk increases if Actos is used for more than two years, or if someone takes more than 28,000 milligrams over the course of their lives. The overall risk is small, however. Still, "the more you accumulate the drug into your system, the higher the risk," said senior researcher Laurent Azoulay, an associate professor of oncology at McGill University in Montreal. Azoulay and his colleagues did not find a similar link between bladder ... Read more

Related support groups: Diabetes, Type 2, Insulin Resistance, Actos, Pre-Diabetes, Diabetes Mellitus, Pioglitazone, Avandia, Bladder Cancer, ActoPlus Met, Avandamet, Metformin/Pioglitazone, Abnormal Glucose Tolerance, Rosiglitazone, Oseni, ActosPlus Met, Alogliptin/pioglitazone, Glimepiride/Pioglitazone, Avandaryl, Glimepiride/Rosiglitazone, Duetact

Hormone Exposure in Womb May Boost Later Type 2 Diabetes Risk

Posted 24 Mar 2016 by Drugs.com

THURSDAY, March 24, 2016 – Exposure to the hormone leptin in the womb may increase a child's risk of developing type 2 diabetes, a new mouse study suggests. Leptin is secreted by fat cells. It helps maintain energy balance in the body, the study authors explained. The findings from experiments in mice could improve understanding of how type 2 diabetes develops in children, particularly for those with obese mothers, the researchers said. It's important to note, however, that animal research often doesn't produce similar results in humans. The study was published online March 24 in the journal Cell Reports. "We showed that exposure of the embryonic mouse brain to leptin during a key developmental period resulted in permanent alternations in the growth of neurons from the brain stem to the pancreas, resulting in long-term disturbances to the balance of insulin levels in the adult mouse," ... Read more

Related support groups: Diabetes, Type 2, Obesity, Labor and Delivery including Augmentation

Health Tip: Setting Goals for a Healthier Lifestyle

Posted 24 Mar 2016 by Drugs.com

-- If you're at risk for type 2 diabetes, making some lifestyle changes can help you keep the disease at bay. The American Diabetes Association suggests: Evaluate the changes you need to make, and choose those you want to make first. Don't try to change too much at once. Keep your change goals short-term, realistic and specific. Set one or two eating-related goals, and one physical activity goal. Make goals specific, such as swapping your nightly bowl of ice cream for a bowl of fruit. Don't just make it a goal to eat more fruit. Write down your goals (one to three at a time is ideal) and put them somewhere visible, such as on your mirror. Read more

Related support groups: Diabetes, Type 2, Insulin Resistance, Pre-Diabetes, Diabetes Mellitus, Abnormal Glucose Tolerance

Women May Not Be Aware of Heart Disease Risks

Posted 24 Mar 2016 by Drugs.com

WEDNESDAY, March 23, 2016 – Many American women have heart disease risk factors, but few are properly informed of their risk by doctors, a new study finds. Researchers conducted an online survey of 1,000 women nationwide and found that 74 percent had at least one heart disease risk factor, including high blood pressure, high cholesterol, diabetes, irregular menstrual cycle, early menopause or a family history of heart disease. Women who were younger, lower-income or minority were the least likely to be aware of their heart disease risk factors. These same groups of women were also least likely to know that heart disease is the number one killer of both men and women, the researchers said. Only 16 percent of those women were told by a doctor that they were at risk for heart disease. About one-third were advised to lose weight, the study revealed. Nearly half of the women in the study ... Read more

Related support groups: High Blood Pressure, Diabetes, Type 2, Obesity, Hypertension, High Cholesterol, Menopausal Disorders, Menstrual Disorders, Premenstrual Syndrome, Period Pain, Dysmenorrhea, Hypertensive Heart Disease

A Wearable Patch Might Help Manage Diabetes Painlessly

Posted 22 Mar 2016 by Drugs.com

MONDAY, March 21, 2016 – An experimental device might one day literally take the pain out of managing diabetes, Korean researchers say. The new invention uses a patch to monitor blood sugar levels via sweat, and delivers the diabetes drug metformin through the skin with microneedles. "Diabetics are reluctant to monitor their blood glucose levels because of the painful blood-gathering process," said study author Hyunjae Lee, from Seoul National University in the Republic of Korea. "We highly focused on a noninvasive monitoring and therapy system for diabetics." The findings were published online March 21 in the journal Nature Nanotechnology. The study team was led by Dae-Hyeong Kim, at Seoul National University. Funding for the study was provided by the Institute for Basic Science in the Republic of Korea. Currently, people with diabetes have two options for monitoring blood sugar ... Read more

Related support groups: Diabetes, Type 2, Diabetes, Type 1, Insulin Resistance, Pre-Diabetes, Diabetes Mellitus, Diabetic Ketoacidosis (DKA), Diagnosis and Investigation, Gestational Diabetes, Abnormal Glucose Tolerance, Intravenous Insulin Drip

Diabetes May Raise Risk for Dangerous Staph Infection

Posted 11 Mar 2016 by Drugs.com

FRIDAY, March 11, 2016 – People with diabetes may be significantly more likely to develop potentially deadly "staph" blood infections than those without diabetes, a new study suggests. As the Danish researchers explained, Staphyloccus aureus bacteria live on the skin and are normally harmless. However, the germs can cause dangerous infections if they enter the bloodstream. In fact, the 30-day death rate from such infections is 20 percent to 30 percent, according to the research team from Aalborg University Hospital and Aarhus University Hospital. In their new study, the researchers tracked the medical records of 30,000 people in Denmark over 12 years. Overall, they found that people with any form of diabetes were almost three times more likely to acquire a staph blood infection outside of a hospital, compared to those without diabetes. The risk jumped to more than seven times higher ... Read more

Related support groups: Infections, Diabetes, Type 2, Diabetes, Type 1, Methicillin-Resistant Staphylococcus Aureus Infection, Diabetic Neuropathy, Diabetic Nerve Damage, Insulin Resistance, Pre-Diabetes, Diabetes Mellitus, Abnormal Glucose Tolerance

Triggers for Hyperglycemia

Posted 10 Mar 2016 by Drugs.com

-- Some people with diabetes may wonder what causes elevated blood sugar, medically called hyperglycemia. The American Diabetes Association explains these potential causes: Taking an insufficient insulin dose. Getting insufficient exercise. Eating too much. Being under emotional stress. Having a cold or the flu. Read more

Related support groups: Diabetes, Type 2, Insulin, Diabetes, Type 1, Diabetic Neuropathy, Insulin Resistance, Diabetic Nerve Damage, Pre-Diabetes, Diabetes Mellitus, Diabetic Ketoacidosis (DKA), Abnormal Glucose Tolerance, Diabetic Coma

Diabetes Treatment May Affect Breast Density

Posted 9 Mar 2016 by Drugs.com

WEDNESDAY, March 9, 2016 – Women with diabetes who take insulin appear to have a higher risk of dense breasts, a known risk factor for breast cancer, new research suggests. Women with diabetes who take insulin "have considerably increased breast density [compared to] women without diabetes," said study lead researcher Zorana Andersen. She's an associate professor of epidemiology at the University of Southern Denmark in Esjberg. Conversely, women taking the oral medication metformin instead of insulin to treat their diabetes seem less likely to have dense breasts, Andersen said. Women with breasts that were more than 75 percent dense had a four to six times higher risk of breast cancer than women whose breasts were fattier, with a density of less than 25 percent, the researchers said. Andersen and her team emphasized that, while insulin treatment was linked with greater chances of ... Read more

Related support groups: Diabetes, Type 2, Insulin, Breast Cancer, Diabetes, Type 1, Insulin Resistance, Pre-Diabetes, Diabetes Mellitus, Breast Cancer, Prevention, Abnormal Glucose Tolerance, Intravenous Insulin Drip

MS Patients May Be Prone to Other Chronic Illnesses, Study Finds

Posted 9 Mar 2016 by Drugs.com

WEDNESDAY, March 9, 2016 – People with multiple sclerosis (MS) are more likely to have other chronic health problems than those without the nervous system disorder, a new study indicates. Researchers looked at how common several chronic conditions – high blood pressure, diabetes, high cholesterol, heart disease, chronic lung disease, epilepsy, fibromyalgia, inflammatory bowel disease, depression, anxiety, bipolar disorder and schizophrenia – were in nearly 23,400 people newly diagnosed with MS and more than 116,600 people without MS. The MS patients had higher rates of all the conditions, with high cholesterol being the exception. Their rates of mental illness, particularly depression, were also high. Nineteen percent of MS patients and 9 percent of those without MS had depression, the study found. For many of the chronic conditions, there were significant gender differences. High ... Read more

Related support groups: High Blood Pressure, Diabetes, Type 2, Seizures, Hypertension, Asthma, Heart Disease, Chronic Obstructive Pulmonary Disease, Multiple Sclerosis, Epilepsy, High Cholesterol, Heart Attack, Schizophrenia, Mania, Schizoaffective Disorder, Angina, Diabetic Neuropathy, Seizure Prevention, Upper Respiratory Tract Infection, Diabetic Nerve Damage, Insulin Resistance

Health Care Apps Often Offer Little Privacy Protection: Study

Posted 9 Mar 2016 by Drugs.com

WEDNESDAY, March 9, 2016 – If you're relying on your smartphone to share medical information with your doctor, you may be risking the privacy of your health records, a new study warns. The new research finds that privacy policies for health programs – or "apps" – designed for smartphones that share highly sensitive medical information between patients and doctors are lacking, and often are completely missing. The study looked specifically at diabetes-related apps marketed to Android-phone users. But, the problem doesn't stop there, the researchers said. "Our findings apply not just to 'Google Play' or diabetes apps specifically, but all health apps and potentially apps in general," said study lead author and lawyer Sarah Blenner. She's with the Illinois Institute of Technology Chicago-Kent College of Law in Chicago. "And the issue is that people in general are probably not aware that ... Read more

Related support groups: Diabetes, Type 2, Diabetes Mellitus, Cardiovascular Risk Reduction, Abnormal Glucose Tolerance

Doctors May Be Missing Chances to Treat Prediabetes

Posted 9 Mar 2016 by Drugs.com

WEDNESDAY, March 9, 2016 – A large number of Americans with prediabetes aren't being treated for the condition, which suggests that doctors are missing opportunities to prevent diabetes, researchers report. More than one-third of U.S. adults have prediabetes, which means their blood sugar levels are higher than normal, but not high enough to be diagnosed with diabetes. People with prediabetes are at increased risk for circulatory problems, kidney disease, and nerve and retinal damage, the study authors said. "We know that prediabetes is considered one of the biggest risk factors for the development of diabetes, with estimates ranging from 15 to 30 percent of people with prediabetes developing diabetes within five years," said lead investigator Arch Mainous III. Mainous is chair of the department of health services research, management and policy in the College of Public Health and ... Read more

Related support groups: Diabetes, Type 2, Insulin Resistance, Pre-Diabetes, Diabetes Mellitus, Abnormal Glucose Tolerance, Gestational Diabetes

Health Tip: If You Have a Wart

Posted 8 Mar 2016 by Drugs.com

-- Warts are skin growths that usually are harmless and can be treated without a doctor's care. But sometimes you should see a doctor about a wart. The American Academy of Dermatology explains these warning signs that an office visit is needed: Suspecting that the growth may not actually be a wart. Having a wart on the genitals or face. Developing a lot of warts, or warts that bleed, burn, itch or cause pain. Having a weakened immune system or being diabetic. Diabetics should never try to remove warts on the feet. Read more

Related support groups: Diabetes, Type 2, Diabetes, Type 1, Warts, Diabetes Mellitus, Abnormal Glucose Tolerance

Page 1 2 3 4 5 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Diabetic Ketoacidosis (in DM Type II), Diabetic Coma (in DM Type II), Diabetes Mellitus

Related Drug Support Groups

metformin, Victoza, Lantus, Januvia, Glucophage, Novolog, glipizide, Humalog, Janumet, view more... Welchol, Byetta, glyburide, Bydureon, Lantus Solostar, Actos, Levemir, Invokana, glimepiride, Amaryl, Novolin R, bromocriptine, Onglyza, Trulicity, chromium picolinate, Novolin N, pioglitazone, liraglutide, Avandia, Humulin N, Tradjenta, Glucophage XR, Humulin R, NovoLog FlexPen, GlipiZIDE XL, Prandin, Glucotrol, Farxiga, Symlin, Humalog KwikPen, sitagliptin, ActoPlus Met, Tanzeum, acarbose, Glucotrol XL, Glumetza, Jardiance, insulin glargine, Apidra, Humalog Pen, Novolin 70 / 30, colesevelam, glyburide / metformin, Humalog Mix 75 / 25, nateglinide, Janumet XR, Afrezza, Starlix, gotu kola, Avandamet, Toujeo, Symlin Pen, NovoLog Mix 70 / 30, Jentadueto, Glucovance, DiaBeta, lavender, insulin regular, linagliptin, rosiglitazone, Humulin N Pen, metformin / pioglitazone, exenatide, Novolin R PenFill, repaglinide, Glyxambi, Cycloset, Oseni, saxagliptin, Tresiba, Nesina, Fortamet, Kombiglyze XR, Ryzodeg 70 / 30, NPH Insulin, alogliptin, miglitol, insulin aspart, dulaglutide, Precose, Riomet, SymlinPen 60, metformin / sitagliptin, Exubera, Insulin Pork Mix, Humulin 70 / 30, ReliOn / Novolin 70 / 30, Glynase, Novolin N Innolet, Apidra Solostar, Humalog Mix 50 / 50 KwikPen, Iletin NPH, insulin degludec, PrandiMet, insulin lispro / insulin lispro protamine, Novolin N PenFill, Novolin R Innolet, Synjardy, Invokamet, Humulin 70 / 30 Pen, chlorpropamide, Humalog Mix 50 / 50 Pen, alogliptin / pioglitazone, glimepiride / pioglitazone, dapagliflozin, glipizide / metformin, Kazano, Humulin U, ReliOn / Novolin N, insulin detemir, NovoLog PenFill, tolazamide, Xigduo XR, Micronase, Basaglar, canagliflozin, NovoLog Mix 70 / 30 FlexPen, Novolog Mix 70 / 30 PenFill, ReliOn / Novolin R, insulin zinc, insulin zinc extended, insulin isophane, acetohexamide, Toujeo Solostar, Preflin, ReliOn / Humulin R, glimepiride / rosiglitazone, insulin aspart / insulin aspart protamine, insulin glulisine, Humalog Mix 75 / 25 KwikPen, insulin lispro, insulin isophane / insulin regular, insulin inhalation, rapid acting, Juvisync, SymlinPen 120, Insulin Lente Pork, Tolinase, linagliptin / metformin, alogliptin / metformin, steviocalcitriol, simvastatin / sitagliptin, metformin / saxagliptin, Duetact, tolbutamide, troglitazone, metformin / repaglinide, Glyset, albiglutide, empagliflozin / metformin, Metaglip, insulin aspart / insulin degludec, Diabinese, empagliflozin / linagliptin, dapagliflozin / metformin, empagliflozin, canagliflozin / metformin, Lente Iletin II, Glycron, Avandaryl, Dymelor, Iletin II Lente Pork, Iletin Lente, Novolin L, Humulin L, metformin / rosiglitazone, Humulin 50 / 50, Humalog Mix 75 / 25 Pen, Humalog Mix 50 / 50, Novolin 70 / 30 PenFill, Novolin 70 / 30 Innolet, Iletin II NPH Pork, Insulin Purified NPH Pork, Tol-Tab, Orinase, Glynase PresTab, pramlintide, Rezulin, Cr-GTF, Iletin Regular, Velosulin BR, Iletin II Regular Pork, Chromium GTF, Lantus OptiClik Cartridge